I am popping back from my S4ME holiday to highlight the fact that in Jeroen Den Dunnen's talk, two of the subgroups groups of LC patients his team identified had markers of neuronal damage and elevated type 1 interferons respectively, which fits well with a couple of the hypotheses we've been discussing on here lately.
I know there's a lot of skepticism about autoantibodies generally on here, and mouse models of this kind as well, and I'm certainly not super convinced by the autoantibody story myself but his talk is interesting, and they seem to have a comprehensive plan of where to go next, so I look forward to seeing how their research progresses.